Disc Medicine Stock Price Patterns
| IRON Stock | 77.32 1.23 1.57% |
Momentum 30
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (1.56) | EPS Estimate Current Year (5.96) | EPS Estimate Next Year (6.61) | Wall Street Target Price 122.0833 | EPS Estimate Current Quarter (1.48) |
Using Disc Medicine hype-based prediction, you can estimate the value of Disc Medicine from the perspective of Disc Medicine response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Disc Medicine using Disc Medicine's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Disc using crowd psychology based on the activity and movement of Disc Medicine's stock price.
Disc Medicine Short Interest
An investor who is long Disc Medicine may also wish to track short interest. As short interest increases, investors should be becoming more worried about Disc Medicine and may potentially protect profits, hedge Disc Medicine with its derivative instruments, or be ready for some potential downside.
200 Day MA 66.3202 | Short Percent 0.1253 | Short Ratio 6.16 | Shares Short Prior Month 3.8 M | 50 Day MA 84.0474 |
Disc Medicine Hype to Price Pattern
Investor biases related to Disc Medicine's public news can be used to forecast risks associated with an investment in Disc. The trend in average sentiment can be used to explain how an investor holding Disc can time the market purely based on public headlines and social activities around Disc Medicine. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Disc Medicine's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Disc Medicine.
Disc Medicine Implied Volatility | 1.1 |
Disc Medicine's implied volatility exposes the market's sentiment of Disc Medicine stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Disc Medicine's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Disc Medicine stock will not fluctuate a lot when Disc Medicine's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Disc Medicine to buy its stock at a price that has no basis in reality. In that case, they are not buying Disc because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Disc Medicine after-hype prediction price | USD 77.32 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Disc contract
Based on the Rule 16, the options market is currently suggesting that Disc Medicine will have an average daily up or down price movement of about 0.0688% per day over the life of the 2026-03-20 option contract. With Disc Medicine trading at USD 77.32, that is roughly USD 0.0532 . If you think that the market is fully incorporating Disc Medicine's daily price movement you should consider acquiring Disc Medicine options at the current volatility level of 1.1%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Disc Medicine Basic Forecasting Models to cross-verify your projections. Disc Medicine After-Hype Price Density Analysis
As far as predicting the price of Disc Medicine at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Disc Medicine or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Disc Medicine, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Disc Medicine Estimiated After-Hype Price Volatility
In the context of predicting Disc Medicine's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Disc Medicine's historical news coverage. Disc Medicine's after-hype downside and upside margins for the prediction period are 74.50 and 80.14, respectively. We have considered Disc Medicine's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Disc Medicine is very steady at this time. Analysis and calculation of next after-hype price of Disc Medicine is based on 3 months time horizon.
Disc Medicine Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Disc Medicine is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Disc Medicine backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Disc Medicine, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.13 | 2.84 | 0.40 | 0.10 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
77.32 | 77.32 | 0.00 |
|
Disc Medicine Hype Timeline
Disc Medicine is currently traded for 77.32. The entity has historical hype elasticity of 0.4, and average elasticity to hype of competition of 0.1. Disc is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 93.11%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.13%. %. The volatility of related hype on Disc Medicine is about 364.57%, with the expected price after the next announcement by competition of 77.42. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.37. Disc Medicine had not issued any dividends in recent years. The entity had 1:30 split on the 30th of December 2022. Given the investment horizon of 90 days the next estimated press release will be in about 10 days. Check out Disc Medicine Basic Forecasting Models to cross-verify your projections.Disc Medicine Related Hype Analysis
Having access to credible news sources related to Disc Medicine's direct competition is more important than ever and may enhance your ability to predict Disc Medicine's future price movements. Getting to know how Disc Medicine's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Disc Medicine may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LEGN | Legend Biotech Corp | 0.49 | 9 per month | 0.00 | (0.28) | 3.83 | (6.84) | 19.65 | |
| ZLAB | Zai Lab | (0.28) | 7 per month | 0.00 | (0.29) | 4.56 | (4.03) | 10.32 | |
| TARS | Tarsus Pharmaceuticals | 1.08 | 8 per month | 0.00 | (0.05) | 3.78 | (3.76) | 12.48 | |
| SRRK | Scholar Rock Holding | 1.56 | 10 per month | 2.41 | 0.14 | 5.92 | (4.21) | 31.68 | |
| AAPG | Ascentage Pharma Group | (2.39) | 9 per month | 0.00 | (0.16) | 5.25 | (6.36) | 16.72 | |
| CELC | Celcuity LLC | 6.54 | 14 per month | 2.07 | 0.17 | 6.70 | (2.93) | 17.89 | |
| ADPT | Adaptive Biotechnologies Corp | (0.36) | 11 per month | 3.84 | 0.04 | 9.94 | (4.95) | 29.55 | |
| CGON | CG Oncology Common | 0.33 | 9 per month | 2.59 | 0.06 | 5.15 | (4.40) | 33.66 | |
| APGE | Apogee Therapeutics Common | 1.96 | 8 per month | 2.68 | 0.08 | 4.52 | (3.96) | 23.21 | |
| XENE | Xenon Pharmaceuticals | (1.14) | 10 per month | 0.00 | (0.03) | 3.78 | (2.71) | 10.56 |
Disc Medicine Additional Predictive Modules
Most predictive techniques to examine Disc price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Disc using various technical indicators. When you analyze Disc charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Disc Medicine Predictive Indicators
The successful prediction of Disc Medicine stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Disc Medicine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Disc Medicine based on analysis of Disc Medicine hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Disc Medicine's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Disc Medicine's related companies.
Pair Trading with Disc Medicine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Disc Medicine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Disc Medicine will appreciate offsetting losses from the drop in the long position's value.Moving together with Disc Stock
Moving against Disc Stock
| 0.78 | IPSC | Century Therapeutics | PairCorr |
| 0.76 | FHTX | Foghorn Therapeutics | PairCorr |
| 0.62 | MAIA | MAIA Biotechnology | PairCorr |
| 0.61 | HOOK | Hookipa Pharma | PairCorr |
| 0.6 | IVA | Inventiva Sa | PairCorr |
| 0.5 | GMAB | Genmab AS | PairCorr |
The ability to find closely correlated positions to Disc Medicine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Disc Medicine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Disc Medicine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Disc Medicine to buy it.
The correlation of Disc Medicine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Disc Medicine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Disc Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Disc Medicine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Disc Medicine Basic Forecasting Models to cross-verify your projections. To learn how to invest in Disc Stock, please use our How to Invest in Disc Medicine guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Will Biotechnology sector continue expanding? Could Disc diversify its offerings? Factors like these will boost the valuation of Disc Medicine. Market participants price Disc higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Disc Medicine data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Disc Medicine using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Disc Medicine's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Disc Medicine's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Disc Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Disc Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Disc Medicine's market price signifies the transaction level at which participants voluntarily complete trades.